PHARMA TECHNOLOGIES LIMITED, Manchester, Regno Unito

Soci (azionariato)

Nome	Partecipazione	Voto	Dal

Beneficiario effettivo

Nome	Partecipazione	Paese	Dal

Bilancio e conti

Cifre chiave dai bilanci depositati.

Convert to

2016

Profit / (loss): £-17

Key figures

Profit / (loss)

2016£-17

2017£3604

2018—

2019—

Total assets

2016£100

2017£100

2018£100

2019£100

Equity

2016—

2017£100

2018£100

2019£100

Current Assets

2016£2033

2017£2033

2018£6492

2019£1131

Net Current Assets Liabilities

2016£83

2017£83

2018£3687

2019£-69

Total Assets Less Current Liabilities

2016£83

2017—

2018—

2019—

Cash Bank On Hand

2016—

2017£1933

2018£6392

2019£176

Debtors

2016£100

2017£100

2018£100

2019£955

Other Debtors

2016—

2017£100

2018£100

2019£100

Creditors

2016—

2017£1950

2018£2805

2019£1200

Other Creditors

2016—

2017£1950

2018£1950

2019£1200

Issue Equity Instruments

2016£100

2017£100

2018—

2019—

Number Shares Allotted

2016100

2017—

2018—

2019—

Number Shares Issued Fully Paid

2016—

2017100

2018100

2019100

Par Value Share

2016£1

2017£1

2018£1

2019£1

Called Up Share Capital

2016£100

2017—

2018—

2019—

Cash Bank In Hand

2016£1933

2017—

2018—

2019—

Corporation Tax Payable

2016—

2017£855

2018£855

2019—

Corporation Tax Recoverable

2016—

2017—

2018£855

2019£855

Creditors Due Within One Year

2016£1950

2017—

2018—

2019—

Net Assets Liabilities Including Pension Asset Liability

2016£83

2017—

2018—

2019—

Profit Loss Account Reserve

2016£-17

2017—

2018—

2019—

Share Capital Allotted Called Up Paid

2016£100

2017—

2018—

2019—

Shareholder Funds

2016£83

2017—

2018—

2019—

Metric	2016	2017	2018	2019
Profit / (loss)	£-17	£3604	—	—
Total assets	£100	£100	£100	£100
Equity	—	£100	£100	£100
Current Assets	£2033	£2033	£6492	£1131
Net Current Assets Liabilities	£83	£83	£3687	£-69
Total Assets Less Current Liabilities	£83	—	—	—
Cash Bank On Hand	—	£1933	£6392	£176
Debtors	£100	£100	£100	£955
Other Debtors	—	£100	£100	£100
Creditors	—	£1950	£2805	£1200
Other Creditors	—	£1950	£1950	£1200
Issue Equity Instruments	£100	£100	—	—
Number Shares Allotted	100	—	—	—
Number Shares Issued Fully Paid	—	100	100	100
Par Value Share	£1	£1	£1	£1
Called Up Share Capital	£100	—	—	—
Cash Bank In Hand	£1933	—	—	—
Corporation Tax Payable	—	£855	£855	—
Corporation Tax Recoverable	—	—	£855	£855
Creditors Due Within One Year	£1950	—	—	—
Net Assets Liabilities Including Pension Asset Liability	£83	—	—	—
Profit Loss Account Reserve	£-17	—	—	—
Share Capital Allotted Called Up Paid	£100	—	—	—
Shareholder Funds	£83	—	—	—

PHARMA TECHNOLOGIES LIMITED

Riepilogo

Dati legali e stato

Timeline (13 events)

Address updated

Annual accounts filed

Appointed Andrew Paul Green (person)

Rete

Proprietà e organi

Persons with significant control

Officers & directors

Ownership Timeline (2 changes)

Appointed Andrew Paul Green (person)

Appointed David Richard Sharples (person)

Soci (azionariato)

Beneficiario effettivo

Geografia

Bilancio e conti

Key figures

Documenti

Company Report of PHARMA TECHNOLOGIES LIMITED

Final Gazette dissolved via voluntary strike-off

First Gazette notice for voluntary strike-off

Strike off from register

Total exemption full accounts made up to 31 December 2019

Companexia Document AI

Confirmation statement

Annual Accounts

Total exemption full accounts made up to 31 December 2018

Change of director details

Confirmation statement

Altre aziende e persone

Financial Health

Growth

Efficiency & returns

Working capital & liquidity

Capital structure